Departments of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.
Departments of Pathology, Johns Hopkins Hospital, Baltimore, MD, USA.
J Gastrointest Surg. 2020 Apr;24(4):841-848. doi: 10.1007/s11605-019-04201-4. Epub 2019 Apr 2.
Improvement in imaging has resulted in frequent diagnosis of benign and premalignant pancreatic tumors. Pancreatic nerve sheath (PNS) tumors are one of the rarest pancreatic tumors. Literature on PNS is limited and their biology is poorly understood. Here, we report the largest series of PNS tumors to date and review the literature to evaluate the current data available on PNS tumors.
An institutional database was used to identify patients who underwent resection for PNS tumors. Clinicopathological characteristics and outcomes of these patients were reported. Furthermore, a review of literature was performed.
From January 1994 through December 2016, seven patients underwent resection for PNS tumors. The median age was 57.7 years (IQR, 44.9-61.9) and the sex was approximately equally distributed (male = 4; 57.1%). Three (42.9%) patients were diagnosed incidentally and six (85.7%) were misdiagnosed as having other pancreatic tumors. The median tumor size was 2.1 (IQR 1.8-3.0) cm and six (85.7%) had no nodal disease. At a median follow-up of 15.5 (IQR 13.7-49.3) months, six patients were alive without evidence of disease and one patient was lost to follow-up. The literature review identified 49 studies reporting 54 patients with PNS tumors. Forty-six were misdiagnosed as having other pancreatic tumors. The median tumor size was 3.6 (range 1-20) cm, nodal disease was present in six patients (22.2%), and no patient had distant metastatic disease. At the time of last follow-up, all patients were free of disease.
This is the largest single institution series on PNS tumors reported to date. These tumors are rare and are often misdiagnosed, given their radiological characteristics. PNS tumors have a benign course of disease and surgical resection results in favorable long-term outcomes.
成像技术的进步导致良性和癌前胰腺肿瘤的诊断频率增加。胰腺神经鞘瘤(PNS)是最罕见的胰腺肿瘤之一。关于 PNS 的文献有限,其生物学特性尚未被充分了解。在此,我们报告了迄今为止最大的 PNS 肿瘤系列,并对文献进行了回顾,以评估目前关于 PNS 肿瘤的可用数据。
使用机构数据库确定接受 PNS 肿瘤切除术的患者。报告这些患者的临床病理特征和结果。此外,还进行了文献复习。
从 1994 年 1 月至 2016 年 12 月,7 名患者因 PNS 肿瘤接受了切除术。中位年龄为 57.7 岁(IQR,44.9-61.9),性别分布大致均衡(男性=4;57.1%)。3 例(42.9%)患者为偶然诊断,6 例(85.7%)误诊为其他胰腺肿瘤。肿瘤大小的中位数为 2.1cm(IQR 1.8-3.0),6 例(85.7%)无淋巴结疾病。中位随访 15.5 个月(IQR 13.7-49.3),6 例患者无疾病存活,1 例患者失访。文献复习共纳入 49 项研究,报道了 54 例 PNS 肿瘤患者。其中 46 例误诊为其他胰腺肿瘤。肿瘤大小的中位数为 3.6cm(范围 1-20),6 例患者存在淋巴结疾病(22.2%),无患者发生远处转移。最后一次随访时,所有患者均无疾病。
这是迄今为止报道的最大的单一机构 PNS 肿瘤系列。鉴于其影像学特征,这些肿瘤较为罕见,且常常被误诊。PNS 肿瘤具有良性的疾病过程,手术切除可获得良好的长期结果。